192 related articles for article (PubMed ID: 2478015)
1. Antithrombin III prophylaxis of venous thromboembolic disease after total hip or total knee replacement.
Francis CW; Pellegrini VD; Harris CM; Marder VJ
Am J Med; 1989 Sep; 87(3B):61S-66S. PubMed ID: 2478015
[TBL] [Abstract][Full Text] [Related]
2. Antithrombin III/low-dose heparin in the prevention of deep-vein thrombosis after total knee arthroplasty. A preliminary report.
Stulberg BN; Francis CW; Pellegrini VD; Miller ML; Shull S; deSwart R; Easley K; Totterman S; Marder VJ
Clin Orthop Relat Res; 1989 Nov; (248):152-7. PubMed ID: 2478330
[TBL] [Abstract][Full Text] [Related]
3. Prevention of venous thrombosis after total knee arthroplasty. Comparison of antithrombin III and low-dose heparin with dextran.
Francis CW; Pellegrini VD; Stulberg BN; Miller ML; Totterman S; Marder VJ
J Bone Joint Surg Am; 1990 Aug; 72(7):976-82. PubMed ID: 1696577
[TBL] [Abstract][Full Text] [Related]
4. Prevention of venous thrombosis after total hip arthroplasty. Antithrombin III and low-dose heparin compared with dextran 40.
Francis CW; Pellegrini VD; Marder VJ; Harris CM; Totterman S; Gabriel KR; Baughman DJ; Roemer S; Burke J; Goodman TL
J Bone Joint Surg Am; 1989 Mar; 71(3):327-35. PubMed ID: 2466846
[TBL] [Abstract][Full Text] [Related]
5. Prophylaxis of venous thrombosis following total hip and total knee replacement using antithrombin III and heparin.
Francis CW; Pellegrini VD; Harris CM; Stulberg B; Gabriel KR; Marder VJ
Semin Hematol; 1991 Jan; 28(1):39-45. PubMed ID: 2017691
[No Abstract] [Full Text] [Related]
6. A fixed-dose combination of low molecular weight heparin with dihydroergotamine versus adjusted-dose unfractionated heparin in the prevention of deep-vein thrombosis after total hip replacement.
Horbach T; Wolf H; Michaelis HC; Wagner W; Hoffmann A; Schmidt A; Beck H
Thromb Haemost; 1996 Feb; 75(2):246-50. PubMed ID: 8815569
[TBL] [Abstract][Full Text] [Related]
7. A comparative study of dextran-70, warfarin and low-dose heparin for the prophylaxis of thrombo-embolism following total hip replacement.
Barber HM; Feil EJ; Galasko CS; Edwards DH; Sutton RA; Haynes DW; Bentley G
Postgrad Med J; 1977 Mar; 53(617):130-3. PubMed ID: 859784
[TBL] [Abstract][Full Text] [Related]
8. RD heparin compared with warfarin for prevention of venous thromboembolic disease following total hip or knee arthroplasty. RD Heparin Arthroplasty Group.
J Bone Joint Surg Am; 1994 Aug; 76(8):1174-85. PubMed ID: 8056798
[TBL] [Abstract][Full Text] [Related]
9. Low molecular weight heparin compared with dextran as prophylaxis against thrombosis after total hip replacement.
Mätzsch T; Bergqvist D; Fredin H; Hedner U
Acta Chir Scand; 1990; 156(6-7):445-50. PubMed ID: 1695053
[TBL] [Abstract][Full Text] [Related]
10. A meta-analysis of methods to prevent venous thromboembolism following total hip replacement.
Imperiale TF; Speroff T
JAMA; 1994 Jun; 271(22):1780-5. PubMed ID: 7515115
[TBL] [Abstract][Full Text] [Related]
11. Clinical experience with antithrombin III concentrate in treatment of congenital and acquired deficiency of antithrombin. The Antithrombin III Study Group.
Schwartz RS; Bauer KA; Rosenberg RD; Kavanaugh EJ; Davies DC; Bogdanoff DA
Am J Med; 1989 Sep; 87(3B):53S-60S. PubMed ID: 2679072
[TBL] [Abstract][Full Text] [Related]
12. Safety and efficacy of a low molecular weight heparin (Logiparin) versus dextran as prophylaxis against thrombosis after total hip replacement.
Mätzsch T; Bergqvist D; Fredin H; Hedner U
Acta Chir Scand Suppl; 1988; 543():80-4. PubMed ID: 2461017
[TBL] [Abstract][Full Text] [Related]
13. A comparison of subcutaneous low-molecular-weight heparin with warfarin sodium for prophylaxis against deep-vein thrombosis after hip or knee implantation.
Hull R; Raskob G; Pineo G; Rosenbloom D; Evans W; Mallory T; Anquist K; Smith F; Hughes G; Green D
N Engl J Med; 1993 Nov; 329(19):1370-6. PubMed ID: 8413432
[TBL] [Abstract][Full Text] [Related]
14. A meta-analysis of thromboembolic prophylaxis following elective total hip arthroplasty.
Freedman KB; Brookenthal KR; Fitzgerald RH; Williams S; Lonner JH
J Bone Joint Surg Am; 2000 Jul; 82-A(7):929-38. PubMed ID: 10901307
[TBL] [Abstract][Full Text] [Related]
15. Prevention of deep vein thrombosis after hip replacement: randomised comparison between unfractionated heparin and low molecular weight heparin.
Leyvraz PF; Bachmann F; Hoek J; Büller HR; Postel M; Samama M; Vandenbroek MD
BMJ; 1991 Sep; 303(6802):543-8. PubMed ID: 1655136
[TBL] [Abstract][Full Text] [Related]
16. The use of dihydroergotamine and heparin in the prophylaxis of deep venous thrombosis.
Comerota AJ; White JV
Chest; 1986 May; 89(5 Suppl):389S-395S. PubMed ID: 3698718
[TBL] [Abstract][Full Text] [Related]
17. Prophylaxis of postoperative venous thrombosis in a controlled trial comparing dextran 70 and low-dose heparin.
Bergqvist D; Hallböök T
World J Surg; 1980; 4(2):239-43. PubMed ID: 6157256
[TBL] [Abstract][Full Text] [Related]
18. The prevention of postoperative deep vein thrombosis and pulmonary embolism with low dose subcutaneous heparin and dextran.
Verstraete M
Surg Gynecol Obstet; 1976 Dec; 143(6):981-5. PubMed ID: 996722
[TBL] [Abstract][Full Text] [Related]
19. A randomized controlled trial of a low-molecular-weight heparin (enoxaparin) to prevent deep-vein thrombosis in patients undergoing elective hip surgery.
Turpie AG; Levine MN; Hirsh J; Carter CJ; Jay RM; Powers PJ; Andrew M; Hull RD; Gent M
N Engl J Med; 1986 Oct; 315(15):925-9. PubMed ID: 3531851
[TBL] [Abstract][Full Text] [Related]
20. Low molecular weight heparin (enoxaparin) compared with unfractionated heparin in prophylaxis of deep venous thrombosis and pulmonary embolism in patients undergoing hip replacement.
Avikainen V; von Bonsdorff H; Partio E; Kaira P; Hakkinen S; Usenius JP; Kaaja R
Ann Chir Gynaecol; 1995; 84(1):85-90. PubMed ID: 7645915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
